| 000 | 01477 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516033518.0 | ||
| 264 | 0 | _c20110607 | |
| 008 | 201106s 0 0 rus d | ||
| 022 | _a0042-4625 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBogomolov, M S | |
| 245 | 0 | 0 |
_a[The results of using cytoflavin in conservative treatment of patients with obliterating atherosclerosis of the lower extremity vessels]. _h[electronic resource] |
| 260 |
_bVestnik khirurgii imeni I. I. Grekova _c2011 |
||
| 300 |
_a43-6 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aArteriosclerosis Obliterans _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFlavin Mononucleotide _xadministration & dosage |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 |
_aInosine Diphosphate _xadministration & dosage |
| 650 | 0 | 4 |
_aLeg _xblood supply |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNiacinamide _xadministration & dosage |
| 650 | 0 | 4 |
_aSuccinates _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aWalking _xphysiology |
| 700 | 1 | _aSedov, V M | |
| 700 | 1 | _aEdovina, L N | |
| 700 | 1 | _aLuk'ianov, Iu V | |
| 700 | 1 | _aSlobodianiuk, V V | |
| 773 | 0 |
_tVestnik khirurgii imeni I. I. Grekova _gvol. 170 _gno. 1 _gp. 43-6 |
|
| 999 |
_c20771937 _d20771937 |
||